Page 75 - TD-3-3

Tumor Discovery Pyroptosis-related genes in breast cancer progression

Oncogene. 2014;33(26):3374-3382. doi: 10.1016/j.canlet.2020.10.004
doi: 10.1038/onc.2013.337 31. Shen B, Chapman JH, Custance MF, Tricola GM, Jones CE,
Furano AV. Perturbation of base excision repair sensitizes
21. Bougeret C, Jiang S, Keydar I, Avraham H. Functional
analysis of Csk and CHK kinases in breast cancer cells. J Biol breast cancer cells to APOBEC3 deaminase-mediated
mutations. Elife. 2020;9:e51605.
Chem. 2001;276(36):33711-33720.
doi: 10.7554/eLife.51605
doi: 10.1074/jbc.M104209200
32. Smith NJ, Fenton TR. The APOBEC3 genes and their role
22. Kim S, Zagozdzon R, Meisler A, et al. Csk homologous in cancer: Insights from human papillomavirus. J Mol
kinase (CHK) and ErbB-2 interactions are directly coupled Endocrinol. 2019;62(4):R269-R287.
with CHK negative growth regulatory function in breast
cancer. J Biol Chem. 2002;277(39):36465-36470. doi: 10.1530/JME-19-0011
doi: 10.1074/jbc.M206018200 33. Law EK, Levin-Klein R, Jarvis MC, et al. APOBEC3A
catalyzes mutation and drives carcinogenesis in vivo. J Exp
23. Ranzato E, Martinotti S, Magnelli V, et al. Epigallocatechin- Med. 2020;217(12):e20200261.
3-gallate induces mesothelioma cell death via H2O2-
dependent T-type Ca2+ channel opening. J Cell Mol Med. doi: 10.1084/jem.20200261
2012;16(11):2667-2678. 34. Burns MB, Lackey L, Carpenter MA, et al. APOBEC3B is
doi: 10.1111/j.1582-4934.2012.01584.x an enzymatic source of mutation in breast cancer. Nature.
2013;494(7437):366-370.
24. Ohkubo T, Yamazaki J. T-type voltage-activated calcium
channel Cav3.1, but not Cav3.2, is involved in the inhibition doi: 10.1038/nature11881
of proliferation and apoptosis in MCF-7 human breast 35. Martín-Pardillos A, Cajal SRY. Characterization of Kelch
cancer cells. Int J Oncol. 2012;41(1):267-275. domain-containing protein 7B in breast tumours and breast
doi: 10.3892/ijo.2012.1422 cancer cell lines. Oncol Lett. 2019;18(3):2853-2860.
25. Maiques O, Macià A, Moreno S, et al. Immunohistochemical doi: 10.3892/ol.2019.10672
analysis of T-type calcium channels in acquired melanocytic 36. Zhao H, Yin X, Wang L, et al. Identifying tumour
naevi and melanoma. Br J Dermatol. 2017;176(5): microenvironment-related signature that correlates with
1247-1258. prognosis and immunotherapy response in breast cancer.
doi: 10.1111/bjd.15121 Sci Data. 2023;10(1):119.
26. Cristofani R, Piccolella M, Crippa V, et al. The role of HSPB8, doi: 10.1038/s41597-023-02032-2
a component of the chaperone-assisted selective autophagy 37. Tian W, Luo Y, Tang Y, et al. Novel implication of the
machinery, in cancer. Cells. 2021;10(2):335. basement membrane for breast cancer outcome and immune
doi: 10.3390/cells10020335 infiltration. Int J Biol Sci. 2023;19:1645-1663.
27. Lackey L, Law EK, Brown WL, Harris RS. Subcellular doi: 10.7150/ijbs.81939
localization of the APOBEC3 proteins during mitosis and 38. Qi A, Ju M, Liu Y, et al. Development of a novel prognostic
implications for genomic DNA deamination. Cell Cycle signature based on antigen processing and presentation in
Georget Tex. 2013;12(5):762-772. patients with breast cancer. Pathol Oncol Res. 2021;27:600727.
doi: 10.4161/cc.23713 doi: 10.3389/pore.2021.600727
28. Huang D, Chen X, Zeng X, et al. Targeting regulator of 39. Bjarnadottir O, Kimbung S, Johansson I, et al. Global
G protein signaling 1 in tumor-specific T cells enhances transcriptional changes following statin treatment in breast
their trafficking to breast cancer. Nat Immunol. 2021;22(7): cancer. Clin Cancer Res. 2015;21(15):3402-3411.
865-879.
doi: 10.1158/1078-0432.CCR-14-1403
doi: 10.1038/s41590-021-00939-9
40. Jeong G, Bae H, Jeong D, et al. A Kelch domain-containing
29. Li Y, Jiao Y, Luo Z, Li Y, Liu Y. High peroxidasin-like KLHDC7B and a long non-coding RNA ST8SIA6-AS1
expression is a potential and independent prognostic act oppositely on breast cancer cell proliferation via the
biomarker in breast cancer. Medicine (Baltimore). interferon signaling pathway. Sci Rep. 2018;8(1):12922.
2019;98(44):e17703.
doi: 10.1038/s41598-018-31306-8
doi: 10.1097/MD.0000000000017703
41. Mumme H, Thomas BE, Bhasin SS, et al. Single-cell analysis
30. Revathidevi S, Murugan AK, Nakaoka H, Inoue I, reveals altered tumor microenvironments of relapse- and
Munirajan AK. APOBEC: A molecular driver in cervical remission-associated pediatric acute myeloid leukemia. Nat
cancer pathogenesis. Cancer Lett. 2021;496:104-116. Commun. 2023;14:6209.

Volume 3 Issue 3 (2024) 16 doi: 10.36922/td.3469